ArticleTobacco control2026
Point-of-sale, court-ordered, cigarette-related corrective statements: population prevalence of exposure and reactions.
Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo estimate the prevalence of US adults' exposure to point-of-sale corrective statements about the health effects, addictiveness, and deceptive marketing of cigarettes, as well as reactions to these messages.
methodsWe analysed data from the 2024 Health Information National Trends Survey, a cross-sectional, nationally representative sample of the US civilian non-institutionalised population aged 18+ (March-September 2024, N=7278). Weighted multivariable logistic regression models estimated associations of tobacco use, sociodemographic characteristics and perceptions of conflicting health recommendations with self-reported exposure and reactions.
resultsIn 2024, 36.5% of US adults reported seeing point-of-sale corrective statements. Individuals who currently smoked (52.9%) were more likely to report exposure compared with those who never (34.7%) or formerly smoked (34.3%). Among those exposed, 53.6% trusted the information, 49.3% supported the court's mandate, 26.5% thought about friends/family who smoke and 7.9% wanted to look for more information about smoking risks. 41.1% of individuals who currently smoked and saw the statements reported thinking about quitting. Multivariable analyses indicated that those who smoked or used non-cigarette tobacco products were more likely to report exposure and less likely to support the mandate, while individuals who believed that health recommendations often conflict were less likely to trust the information.
conclusionsAbout one in three US adults-and about half of people who smoke-reported noticing point-of-sale corrective statements in 2024. Although exposure rates were relatively consistent across sociodemographic groups, variations in individual reactions point to a need for strategies that enhance the impact of corrective statements, particularly among those who smoke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.